NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Company News » Genetesis gets FDA Breakthrough Device Designation for CardioFlux imaging technology » heart-1765298_640(3)

Genetesis gets FDA Breakthrough Device Designation for CardioFlux imaging technology

NS Medical Devices is using cookies

Genetesis’ CardioFlux granted FDA Breakthrough Device Designation. (Credit: Reaper DZ from Pixabay.)

Related Article

The increased importance of supporting decentralised clinical trials during, and after, Covid-19

RECOMMENDED COMPANIES

MOST READ

The increased importance of supporting decentralised clinical trials during, and after, Covid-19

CES 2021: Five of the best medical technologies from this year’s innovation trade show

How could medical device regulation change under president-elect Biden?

Four breakthrough medical devices that could help to treat Alzheimer’s in the future

Could a tiny LED microchip device be a future medical treatment for obesity?

Recommended Whitepaper